Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nordstjernan to invest in medtech company Ascilion

Nordstjernan is investing in Ascilion, a Swedish medtech company founded in 2012 and based in Stockholm, Sweden. Ascilion has developed and patented a technology that uses an array of hollow microneedles to extract the interstitial fluid (ISF) that surrounds the body’s cells and that is a good carrier of biomarkers. Ascilion’s technology has numerous fields of application, including within several branches of medical diagnostics. Nordstjernan will become the second largest owner in Ascilion and, as a partner to the company’s founder and current owners, the aim is to accelerate the company’s

Policy for Responsible investments 2022

Swedbank Robur continuously reviews its policies and strategies and updates their working guidelines, and as of the 1[st] of January 2022, the fund company has further strengthened its Policy for Responsible investments.Among other things, investments in the gambling sector are now excluded. The work on monitoring and reviewing the ongoing sustainability work is clarified, and the Exclusion strategy has been further sharpened. Several new Expectation Papers have also been established. "The continuous reviewing of our guidelines is an important part of our work. By sharpen and clarifying

Herantis Pharma to Participate in the Upcoming Investor Conferences

Herantis Pharma Plc, Press Release, 3 January 2022 at 12:45 EET Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will hold 1x1 meetings and company presentations at the following investor conferences: H.C. Wainwright BioConnect Conference, US - January 10th - 13th, 2022 (Virtual) The presentation will be held on January 10[th] at 14:00 – 14:30 EET / 13:00 – 13:30 CET. 1x1 meetings will be scheduled during January 10-13[th]. Biotech Showcase, US -

Enersense specifies the timetable for the implementation of the P2X investment and partnership arrangement

Enersense International PlcStock exchange release 3 January 2022 at 12:15 p.m.In its release of 8 December 2021, Enersense International Plc (”Enersense”), a provider of zero-emission energy solutions, announced it had signed an agreement on a EUR 13–18 million equity investment in green hydrogen producer P2X Solutions Oy (”P2X”) and related partnership arrangement. The completion of the investment and partnership arrangement was conditional on P2X receiving a significant grant from the Ministry of Economic Affairs and Employment of Finland for the building of the Harjavalta production

Qt Group Plc: Share subscriptions based on stock options 2016

Qt Group Plc, stock exchange release,  3 January 2022, 12:00 noon  EETBetween 14 September and 9 December 2021, a total of 550 Qt Group Plc’s new shares has been subscribed for with the company's stock options 2016. For subscriptions made with the stock options 2016, the entire subscription price of EUR 2,662.00 will be entered in the reserve for invested unrestricted equity. After the trade registration the total amount of shares is 25,181,198. The shares subscribed for under the stock options 2016 have been registered in the Trade Register on 3 January 2022, as of which date the new

Nomination Committee Board Proposals for 2022

To the Annual General Meeting (AGM) on May 10, 2022, the Nomination Committee of Beijer Electronics Group AB has informed the company that it will be proposing following:· that the Board of Directors shall consist of six members. · re-election of Board members Bo Elisson, Ulrika Hagdahl, Johan Wester, Karin Gunnarsson and Lars Eklöf. · new election of Jonas Hård. · election of Bo Elisson as Chairman of the Board. Jonas Hård, born 1971, most recently held the position as Chief Digital Officer for Autoliv Group. Jonas holds an MBA from Henley Business School and General Management

Changes in Etteplan´s Management Group

Etteplan Oyj Stock Exchange Release January 3, 2022 at 11.00 a.m. EET Tero Leppänen, M.Sc. (Computer Science), has been appointed Senior Vice President, Software and Embedded Solutions and a member of Etteplan's Management Group. Leppänen has worked at Etteplan since 2016 in various leadership positions, most recently as Vice President, Testing and Product Verification Business Unit and member of Software and Embedded Solutions service area’s management team. Leppänen joined Etteplan through the acquisition of Espotel Oy in 2016 and prior to that Leppänen worked at Efore Oyj. “I

UPM participates in the Lux Helsinki light festival

(UPM, Helsinki, 03.01.2022 at 11.00 EET) – UPM and the UPM-Kymmene Cultural Foundation will participate in the Lux Helsinki light festival on 5–9 January, which will transform familiar buildings and spaces into unique works of urban art and illuminate the city during the darkest hours of the year. The exterior of UPM's headquarters will feature a 3D video projection by Soil Searchers Collective titled “Its Songs We Sing”, which also includes music. The artwork turns the public’s gaze to the basis of everything, the ground. It reminds us that there is a hidden biological world underground,

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 2 - 3 JANUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 1 - 3 JANUARY 2022 On 4 November 2021, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2021 up to and including no later than end February 2022. For details, please see announcement no. 75 of 4 November 2021. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 263 million).

Biotage moves to the large cap segment

As of today January 3, 2022, Biotage is included in Nasdaq Stockholm’s Large Cap segment. The Large Cap segment includes companies with a market capitalization of more than EUR 1 billion.Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.“Biotage continues to create value for our

BAKKAFROST: Bakkafrost has acquired 90% of the outstanding shares of Munkebo Seafood A/S

In a transaction closed on 1 January 2022, Bakkafrost has acquired 90% of the shares in Munkebo Seafood A/S. The deal was jointly made with Michael Karlsen, who has been the General Manager of Munkebo Seafood for the past many years. The shares were acquired from Paul Lybech, who has been engaged with Munkebo Seafood for almost 25 years. Following the transaction, Michael Karlsen holds 10% of the shares in Munkebo Seafood A/S while Bakkafrost holds 90% of the shares. Munkebo Seafood A/S was founded in 1974 and has since the formation been engaged in production of canned fish at the

Cantargia advances nadunolimab against pancreatic cancer in the PanCAN Precision Promise[SM] phase 2/3 clinical trial

Cantargia AB today announced that the Pancreatic Cancer Action Network’s (PanCAN) Precision Promise[SM] phase 2/3 clinical trial, carried out at leading clinical US centers, plans to include nadunolimab in combination with chemotherapy as first-line experimental therapy in metastatic pancreatic cancer (PDAC). The trial utilizes a Bayesian platform designed by PanCAN in collaboration with the US Food and Drug Administration (FDA) to provide a basis for marketing approval of therapies in PDAC. The primary endpoint for the trial is overall survival. PanCAN’s plan is to submit a Pre-IND

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 30th December 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,834,714 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Metsä Board to purchase all shares in Hämeenkyrön Voima Oy

Metsä Board Corporation press release 3 January 2022Metsä Board, part of Metsä Group, purchases from Pohjolan Voima Oyj all the shares in Hämeenkyrön Voima Oy that it owns. Metsä Board has announced its plan to purchase the shares on 27 September 2021. In addition, Metsä Board will purchase from DL Power Oy, part of Leppäkoski Group, all the shares in Hämeenkyrön Voima Oy that it owns. Both transactions have been completed on 1 January 2022, after which Metsä Board will own 100% of Hämeenkyrön Voima Oy. The transaction will not have a significant impact on Metsä Board's key financial

Sivers Semiconductors receives $2.1m 5G volume order from 8Devices

Sivers Semiconductors AB today announced that the Lithuanian hi-tech company 8devices has placed an order for unlicensed 5G RF modules. The total order value amounts to $ 2.1 million dollars and will be delivered in 2022 starting in the first quarter of 2022. This order is designated for one of 8Device's customers. The customer has the right, within some limitations and early warnings, to cancel or move parts of the order at no charge. The company estimates that the recognized revenue for 2022 will amount to approximately $1.5 million dollars.“It is very nice to start of 2022 with the

Gradientech announces outcome of rights issue

Uppsala, 3 January, 2022. Gradientech AB (publ) (“Gradientech” or “the Company”) announces that the Company's rights issue (the “Rights Issue”), in which the subscription period ended on December 23, 2021, has been completed. The final count in the Rights Issue shows that 3,675,316 shares, corresponding to 90 percent of the Rights Issue, were subscribed for with and without the support of subscription rights. Through the Rights Issue, Gradientech will receive approximately SEK 75.3 million before deductions for transaction costs.OutcomeThe rights issue comprised a maximum of 4,068,607

Drilling of the Ginny exploration well (PL1060) has started

(Trondheim, 3 January 2022) OKEA ASA (OSE: OKEA) announces that drilling operations on the Equinor-operated Ginny exploration well 6407/9-13 have commenced from the West Hercules rig. The well, in production licence PL1060, targets both an Upper Jurassic (Ginny) and a Middle Jurassic (Hermine) prospect located between the Galtvort and Hasselmus discoveries. OKEA holds a 40% working interest in the licence which was awarded in the APA 2019 licensing round. The licence is located NW of the Draugen field which is operated by OKEA (44.56% WI). ‘’This is the first of three exploration

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 3.1.2022, 9.00 AMManagers' transactionsViking Line Abp has January 2, 2022 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from person discharging managerial responsibilities in Viking Line Abp.  Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Maelir ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In IssuerName: Jakob JohanssonPosition:

Faron Appoints Marie-Louise Fjällskog as CMO

Company announcement, January 3, 2022 at 02:00 AM (EST) / 07:00 AM (GMT) / 09:00 AM (EET)TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, is pleased to announce the appointment of Marie-Louise Fjällskog, M.D., Ph.D., as Chief Medical Officer of the Company. Dr. Fjällskog will be based in Boston, MA and her appointment is effective immediately.   Dr. Fjällskog has over 30 years of

Photocure launches Cysview Commercial Operations in Canada

Press release – Oslo, Norway, 3 January 2022: Photocure ASA (Photocure, PHO: OSE) today announces the start of its Cysview[®] sales, marketing and distribution operations in the Canadian market. In August 2021 Photocure had reached an agreement with BioSyent Pharma Inc. (“BioSyent”) to reacquire the marketing and distribution rights to Cysview[ ]in Canada, effective on January 1[st], 2022.The reacquisition of marketing and distribution rights enables Photocure’s direct management of the Cysview brand in Canada and consolidates the territory into Photocure’s existing U.S. business to form

Nanoform sets two new near-term business targets for 2022

Insider information Nanoform Finland Plc January 3, 2022 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform sets two new near-term business targets for 2022 Helsinki, Finland – Nanoform, an innovative nanoparticle medicine enabling company, today announced two new near-term business targets for 2022. Nanoform’s near-term business targets are as follows, where the two first ones are new, while the two latter ones are re-iterated: · At least 20 new customer non-GMP[1] projects in 2022 (+67% vs 2021 target) · At least 3 new customer GMP projects in 2022 (+200% vs

Instalco expands its heating & plumbing business in Norway

Instalco is acquiring Manglerud Rørleggerbedrift AS in Oslo and thereby growing its heating & plumbing operations in Norway. The company is specialized in pipe installations to and from buildings.It was established in 2006 and currently has 14 employees. Sales for the most recent financial year were NOK 25 million. “Manglerud’s specific niche will be an excellent fit with our other heating and plumbing companies in Instalco Norway. Manglerud typically gets involved during the early stages of a project and we see great opportunities for synergies within the Group,” says Roger Aksnes,

Selvaag Bolig ASA: Q4 2021: Best fourth quarter ever

Selvaag Bolig sold 306 homes worth a total of NOK 1 401 million and started construction of 535 in the fourth quarter of 2021. This is a new sales record for the fourth quarter, and the company has not had so many construction starts in a quarter since the IPO in 2012.   “We’ve had a very good year,” says Selvaag Bolig CEO Sverre Molvik. “Sales in all our projects have been stable and good throughout, and were topped off with a fantastic final quarter. These were by far our finest-ever fourth quarter sales, and total sales for the year are the second best in our history.”

There are no items matching the current filter
There are no more items matching the current filter
Back to top